Fixation of Record Date pursuant to scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited for alloting shares to Shareholders of Dhanuka Laboratories Limited
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 10 Jul 2026, 08:36 PM IST · BSE ID: a65edd22-4199-4693-b62c-96c733ab4e29
View Original BSE Filing (PDF)
💡
In Simple Terms
Orchid Pharma completed its merger with Dhanuka Laboratories and set July 23, 2026 to issue shares.
🤖 AI Summary
- Orchid Pharma's Board approved the Dhanuka Laboratories amalgamation, effective July 10, 2026.
- The merger's Appointed Date is April 1, 2024, as per the approved scheme.
- Orchid Pharma's authorized share capital increased to Rs. 164,51,00,000 post-merger.
- Record date set for Thursday, July 23, 2026, for share allotment to Dhanuka Laboratories shareholders.
- Share exchange ratio: 161 Orchid Pharma shares for every 5 Dhanuka Laboratories shares.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Appointed Date of Scheme
1st April, 2024
Effective Date of Scheme
July 10, 2026
New Authorized Share Capital
Rs. 164,51,00,000
New Equity Shares
16,45,10,000
Face Value per Equity Share
Rs. 10/-
Record Date for Share Allotment
Thursday, 23rd July, 2026
Share Exchange Ratio (Orchid Pharma shares)
161
Share Exchange Ratio (Dhanuka Laboratories shares)
5
🏢 How This Affects the Company
The amalgamation integrates Dhanuka Laboratories into Orchid Pharma, potentially expanding the combined entity's product portfolio and market reach.
Orchid Pharma's authorized share capital increased to Rs. 164,51,00,000, reflecting the combined capital structure post-merger. The company will issue new equity shares to Dhanuka Laboratories shareholders.
The completion of the merger means the operational integration of Dhanuka Laboratories with Orchid Pharma is now formally in effect as of July 10, 2026.
👥 What This Means For Shareholders
✅
Action Required
Shareholders of Dhanuka Laboratories Limited who are eligible for shares in Orchid Pharma Limited must ensure their holdings are recorded by July 23, 2026.
👤
Who Is Affected
Shareholders of Dhanuka Laboratories Limited will receive 161 fully paid up equity shares of Orchid Pharma Limited for every 5 fully paid up equity shares held in Dhanuka Laboratories Limited.
🔍
Management Signal
The management's decision indicates a focus on consolidating operations and expanding the company's capital and business scope through strategic acquisition and integration.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Issuance of new Orchid Pharma shares to former Dhanuka Laboratories shareholders.
Integration progress and synergy realization post-amalgamation in Q2/Q3 FY27 results.
Further updates on the combined operational and financial performance.
LOW RISK
This filing confirms the completion of a previously announced merger, reducing uncertainty.
💡 Investor Takeaway
Orchid Pharma has completed its amalgamation with Dhanuka Laboratories effective July 10, 2026, with an Appointed Date of April 1, 2024. The authorized share capital is now Rs. 164,51,00,000. A record date of July 23, 2026, is set for allotting 161 Orchid Pharma shares for every 5 Dhanuka Laboratories shares.
⚖️ Strengths & Concerns
✅ Positives
- Merger completion formalizes the integration of business operations, providing a clearer operational structure from July 10, 2026.
- Increased authorized share capital to Rs. 164,51,00,000 indicates a larger combined entity post-amalgamation.
📅 Company Track Record
Orchid Pharma's amalgamation with Dhanuka Laboratories has been a multi-stage process. The NCLT sanctioned the scheme on June 05, 2026, and the company received the NCLT order on June 12, 2026, with an Appointed Date of April 01, 2024. The merger officially became effective on July 10, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the effective date of the Orchid Pharma and Dhanuka Laboratories merger?
The Scheme of Amalgamation of Dhanuka Laboratories Limited with Orchid Pharma Limited became effective on July 10, 2026.
What is the Appointed Date for the Orchid Pharma and Dhanuka Laboratories amalgamation?
The Appointed Date for the amalgamation as per the scheme is April 1, 2024.
What is Orchid Pharma's authorized share capital after the merger?
Following the merger, Orchid Pharma Limited's authorized share capital is Rs. 164,51,00,000, divided into 16,45,10,000 equity shares of Rs. 10/- each.
When is the record date for share allotment in Orchid Pharma for Dhanuka Laboratories shareholders?
The record date for determining Dhanuka Laboratories Limited shareholders eligible for Orchid Pharma shares is Thursday, July 23, 2026.
What is the share exchange ratio for the Orchid Pharma and Dhanuka Laboratories merger?
Shareholders of Dhanuka Laboratories Limited will receive 161 fully paid up equity shares of Orchid Pharma Limited for every 5 fully paid up equity shares held in Dhanuka Laboratories Limited.
Questions based on this BSE filing only. For information purposes.